Use coupon code: BUCHKUDelivering free antivenoms, restoring humanityGet free delivery on your first order

The recent phase 2 trial of tirzepatide in patients with MASH provides support for the therapeutic potential of GIPpathway modulation in cardiometabolic disease and demonstrates how GIP signaling, when cotargeted with GLP-1RA, may contribute to weight loss, improved metabolic outcomes, and possibly cardiovascular protection ( However, these benefits are accompanied by concerns about side effects, cost, long-term sustainability and, above all, the loss of lean mass, which may be mitigated by concurrent exercise ( Exercise and lifestyle interventions remain foundational for obesity and metabolic disease management, offering broad health benefits, but are often limited by adherence and modest long-term weight loss ( Recent randomized controlled trials and meta-analyses suggest that combining GLP-1RAs with exercise may yield additive or synergistic effects on weight loss and metabolic syndrome severity as well as on oxidative stress and inflammation

So, working with a doctor to develop lifestyle habits that help you transition off the medications effectively may be important
What Dietary Changes Reduce Ketosis-Related Odors Without Wrecking Weight Loss
This is great
Amy Marsteller to talk about GLP-1 receptor agonists, how they work, who may benefit, and what patients should consider before starting them